siRNA-mediated knockdown of VEGF-A, VEGF-C and VEGFR-3 suppresses the growth and metastasis of mouse bladder carcinoma in vivo

Experimental and Therapeutic Medicine

Volumn 1, Issue 5, 2010, Pages 899-904

  Feng, Wang ^a   Li, Hui Ming ^a   Wang, Hui Ping ^a   Ma, Jia Lie ^a   Chen, Xia Fang ^a   Wei, Fang ^a   Yi, Miao Ying ^a   Huang, Qian ^a  

^a SHANGHAI FIRST PEOPLE S HOSPITAL   (China)

Author keywords

Bladder carcinoma; Small interfering RNA; Vascular endothelial growth factor (VEGF) A; VEGF receptor 3; VEGF C

Indexed keywords

GREEN FLUORESCENT PROTEIN; PENTOBARBITAL; SMALL INTERFERING RNA; VASCULOTROPIN A; VASCULOTROPIN C; VASCULOTROPIN RECEPTOR 3;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLADDER CARCINOMA; CANCER GENE THERAPY; CANCER GROWTH; CANCER INHIBITION; CONTROLLED STUDY; ELECTROPORATION; GENE SILENCING; IN VIVO STUDY; INTRACELLULAR SIGNALING; MALE; METASTASIS; MOUSE; NONHUMAN; PROTEIN EXPRESSION; RNA INTERFERENCE; SOLID TUMOR; TUMOR VASCULARIZATION;

EID: 77955198725     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2010.113     Document Type: Article

References (23)

1. Stacher SA, Achen MG, Jussila L, Baldwin ME and Alitalo K: Lymphangiogenesis and cancer metastasis. Nat Rev Cancer 2: 573-583, 2002.
2. Carmeliet P and Jain RK: Angiogenesis in cancer and other diseases. Nature 407: 249-257, 2000.
3. Ferrara N, Gerber HP and LeCouter J: The biology of VEGF and its receptors. Nat Med 9: 669-676, 2003.
4. Saban MR, Towner R, Smith N, et al: Lymphatic vessel density and function in experimental bladder cancer. BMC Cancer 7: 219, 2007.
5. Mylona E, Magkou C, Gorantonakis G, et al: Evaluation of the vascular endothelial growth factor (VEGF)-Crole in urothelial carcinomas of the bladder. Anticancer Res 26: 3567-3571, 2006.
6. Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE and MelloCC: Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391: 806-811, 1998.
7. Ferrara N: Molecular and biological properties of vascular endothelial growth factor. J Mol Med 77: 527-543, 1999.
8. Wang F, Wu JH, Tian YH, et al: Role of VEGF in the growth and metastasis of a murine bladder carcinoma. Chin Sci Bull 48: 2404-2410, 2003.
9. Joukov V, Pajusola K, Kaipainen A, et al: Anovel vascular endothelial growth factor. VEGF-C, is a ligand for the Flt-4 (VEGFR-3) and KDR(VEGFR-2) receptor tyrosine kinases. EMBOJ 15: 290-298, 1996.
10. Oh SJ, Jeltsch MM, Birkenhäger R, et al: VEGF and VEGF-C: specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane. Dev Biol 188: 96-109, 1997.
11. Zu X, Tang Z, Li Y, Gao N, Ding J and Qi L: Vascular endothelial growth factor-Cexpression in bladder transitional cell cancer and its relationship to lymph node metastasis. BJUInt 98: 1090-1093, 2006.
12. Hammond SM, Caudy AA and Hannon GJ: Post-transcriptional gene silencing by double-stranded RNA. Nat Rev Genet 2: 110-119, 2001.
13. Devi GR: siRNA-based approaches in cancer therapy. Cancer Gene Ther 13: 819-829, 2006.
14. Karagiannis TC and El-Osta A: RNAinterference and potential therapeutic applications of short interfering RNAs. Cancer Gene Ther 12: 787-795, 2005.
15. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K and Tuschl T: Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411: 494-498, 2001.
16. Wang F, Tian YH, Chen XF and Huang Q: Microarray analysis the role of VEGF signaling pathway for the growth and metastasis of routine bladder earcinonla. Tumor 27: 847-885, 2007.
17. Sun P, Gao J, Liu YL, Wei LW, Wu LP and Liu ZY: RNA interference (RNAi)-mediated vascular endothelial growth factor-C(VEGF-C) reduction interferes with lymphangiogenesis and enhances epirubicin sensitivity of breast cancer cells. Mol Cell Biochem 308: 161-168, 2008
18. Jia RB, Zhang P, Zhou YX, et al: VEGF-targeted RNA interference suppresses angiogenesis and tumor growth of retinoblastoma. Ophthalmic Res 39: 108-115, 2007.
19. Guan H, Zhou Z, Wang H, Jia SF, Liu W and Kleinerman ES: Asmall interfering RNA targeting vascular endothelial growth factor inhibits Ewing's sarcoma growth in a xenograft mouse model. Clin Cancer Res 11: 2662-2669, 2005.
20. Ioachim HLRH: Tumor-Reactive Lymphadenopathy. 3rd edition. Lippincott Williams and Wilkins, Philadelphia, pp254-258, 2002.
21. Qian CN, Berghuis B, Tsarfaty G, et al: Preparing the 'soil': the primary tumor induces vasculature reorganization in the sentinel lymph node before the arrival of metastatic cancer cells. Cancer Res 66: 10365-10376, 2006.
22. Manoharan M: RNA interference and chemically modified small interfering RNAs. Curr Opin Chem Biol 8: 570-579, 2004.
23. Wang F, Chen XF, Tian YH, Wu JH, Li L, Li CY and HuangQ: Target gene transfer mediated by electroporation for cancer therapy in vivo. Prog Biochem Biophys 29: 734-740, 2002.